Activaero gets €15.7mm through its Series A round
Executive Summary
Activaero GMBH (developed controlled breathing devices used to administer inhaled therapeutics) has raised €10.7mm ($16mm) through the closing of its Series A venture round. BioMedInvest led the financing and was joined by VI Partners AG, Abalis Finance, and Vesalius Biocapital. Each investment company will contribute one member to Activaero's board.
Deal Industry
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Pulmonary
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice